Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionAvidian Wealth Solutions, LLC
Latest Disclosed Ownership13,862 shares
Latest Disclosed Value $ 1,931,992
Avidian Wealth Solutions, LLC reports 25.40% increase in ownership of GILD / Gilead Sciences, Inc.

On May 7, 2026 - Avidian Wealth Solutions, LLC filed a 13F-HR form disclosing ownership of 13,862 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,931,992 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 11,054 shares of Gilead Sciences, Inc.. This represents a change in shares of 25.40% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F GILEAD SCIENCES COM 375558103 13,862 2,808 25.40 1,932 42.40 0.0611
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM 375558103 11,054 500 4.74 1,357 15.80 0.0494
2025-10-30 2025-09-30 13F GILEAD SCIENCES COM 375558103 10,554 510 5.08 1,171 5.21 0.0441
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 10,044 367 3.79 1,114 2.68 0.0453
2025-04-25 2025-03-31 13F GILEAD SCIENCES COM 375558103 9,677 504 5.49 1,084 27.98 0.0483
2025-01-29 2024-12-31 13F GILEAD SCIENCES COM 375558103 9,173 561 6.51 847 17.48 0.0381
2024-10-30 2024-09-30 13F GILEAD SCIENCES COM 375558103 8,612 310 3.73 722 26.71 0.0328
2024-08-06 2024-06-30 13F GILEAD SCIENCES COM 375558103 8,302 1,561 23.16 570 15.42 0.0236
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 6,741 -1,407 -17.27 494 -25.30 0.0240
2024-02-06 2023-12-31 13F GILEAD SCIENCES COM 375558103 8,148 259 3.28 660 11.68 0.0406
2023-10-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 7,889 -204 -2.52 591 -5.14 0.0416
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 8,093 -1,875 -18.81 624 -24.67 0.0408
2023-05-08 2023-03-31 13F GILEAD SCIENCES COM 375558103 9,968 -8 -0.08 827 -3.39 0.0454
2023-02-06 2022-12-31 13F GILEAD SCIENCES COM 375558103 9,976 417 4.36 856 45.08 0.0558
2022-11-03 2022-09-30 13F GILEAD SCIENCES COM 375558103 9,559 -1,549 -13.94 590 -14.12 0.0426
2022-07-29 2022-06-30 13F GILEAD SCIENCES COM 375558103 11,108 1,142 11.46 687 15.85 0.0486
2022-05-10 2022-03-31 13F GILEAD SCIENCES COM 375558103 9,966 707 7.64 593 -11.76 0.0363
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 9,259 15 0.16 672 4.02 0.0418
2021-11-10 2021-09-30 13F GILEAD SCIENCES COM 375558103 9,244 631 7.33 646 8.94 0.0492
2021-08-09 2021-06-30 13F GILEAD SCIENCES COM 375558103 8,613 -137 -1.57 593 4.77 0.0455
2021-05-05 2021-03-31 13F GILEAD SCIENCES COM 375558103 8,750 -701 -7.42 566 2.72 0.0482
2021-02-09 2020-12-31 13F GILEAD SCIENCES COM 375558103 9,451 425 4.71 551 -3.33 0.0522
2021-02-03 2020-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 9,026 3,299 57.60 570 29.25 0.0646
2020-08-10 2020-06-30 13F GILEAD SCIENCES COM 375558103 5,727 1,199 26.48 441 30.09 0.0595
2020-04-22 2020-03-31 13F GILEAD SCIENCES COM 375558103 4,528 21 0.47 339 15.70 0.0544
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 4,507 -3 -0.07 293 2.45 0.0416
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 4,510 304 7.23 286 0.70 0.0471
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 4,206 1,025 32.22 284 37.20 0.0671
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 3,181 3,181 207 0.0460
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.